Chemical | 05 March 2021
MBCC Group acquires Bluey Technologies
The acquisition will help MBCC Group to strengthen portfolio of infrastructure and underground construction chemicals
The acquisition will help MBCC Group to strengthen portfolio of infrastructure and underground construction chemicals
World-class manufacturing base will enhance Asia Pacific customers’ local access to innovative material science solutions
The transaction represents an ideal fit with Barentz' strategy to support customers and principal suppliers through industry-focused sales and technical teams with dedicated coverage in North America
_256_384_256_384.jpg)
Facility to increase production of cleaner-burning fuel additives at Russian petrochemicals refinery
The Indian biotechnology industry is on the cusp of entering a new era.
PA6 and PA66 belong to the most sought-after engineering plastics.
More than 430,000 metric tons CO2 in 2020 avoided by sourcing certified sustainable palm kernel oil
Seeds, crop protection products and digital services for ever more sustainable agricultural solutions
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
A FEED contract was awarded to Aker Solutions in December 2019 for modification work on Åsgard B.
Fragrance products to contain sustainable ethanol, created using carbon-capture technology.
All sustainability activities bundled and assigned to Board of Management members’ portfolios
In the first quarter of this year, Evonik expects adjusted EBITDA of at least €550 million.
Commences development of world's first ammonia-fired 40MW class gas turbine system
The deal is expected to close in the second half of 2021, subject to regulatory approvals and customary closing conditions
Pharma industry is ready to embrace technology platforms with a keen focus on automation in manufacturing and digital health investment.
The well-prepared staff, proper communication with transporters and awareness among people around the chemical plants a need of the hour.
Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).
Bharat Biotech expects to share further details of the trial results as additional data become available.
Subscribe to our newsletter & stay updated.
